argenx SE is a biopharmaceutical company that develops antibody-based medicines for people with severe autoimmune diseases. Its main product is an antibody fragment designed to reduce disease-causing antibodies, and it is used to treat generalised myasthenia gravis and other immune-mediated conditions. The company carries out research and clinical development and works with partners to make its medicines available in markets around the world. It is based in the Netherlands, with additional operations in the United States and Europe.
argenx SE is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1RG34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #903 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendFair
51/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-7.8%
From 52-week high-23.9%
MomentumWeak
44/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-8.4%
6-month return-4.4%
12-month, skipping last month17.0%
Stability (higher is calmer)Fair
54/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)39.7%
Worst drawdown, 1 year (smaller is calmer)-28.5%
LiquidityWeak
27/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M BRL
Zero-volume days56.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 143.22 – 213.15Daily closes, split-adjusted
Signals
50-day average196.84
200-day average175.75
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.97
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
172.8
Bearish
EMA 10
172.5
Bearish
SMA 20
187.0
Bearish
EMA 20
182.1
Bearish
SMA 50
196.8
Bearish
EMA 50
189.6
Bearish
SMA 100
188.4
Bearish
EMA 100
186.8
Bearish
SMA 200
175.8
Bearish
EMA 200
179.2
Bearish
Oscillators (daily)
RSI (14)
19.22
Bullish
MACD (12, 26)
-10.46
Bearish
Momentum (12)
-20.29
Bearish
Stochastic %K (14)
4.91
Bullish
Williams %R (14)
-95.09
Bullish
CCI (20)
-103.9
Bullish
Pivot points (classic, last session)
S3
162.1
S2
162.1
S1
162.1
Pivot
162.1
R1
162.1
R2
162.1
R3
162.1
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
